Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

Publikation: Bidrag til tidsskriftReviewfagfællebedømt

Standard

Advanced heart failure : a position statement of the Heart Failure Association of the European Society of Cardiology. / Crespo-Leiro, Maria G; Metra, Marco; Lund, Lars H; Milicic, Davor; Costanzo, Maria Rosa; Filippatos, Gerasimos; Gustafsson, Finn; Tsui, Steven; Barge-Caballero, Eduardo; De Jonge, Nicolaas; Frigerio, Maria; Hamdan, Righab; Hasin, Tal; Hülsmann, Martin; Nalbantgil, Sanem; Potena, Luciano; Bauersachs, Johann; Gkouziouta, Aggeliki; Ruhparwar, Arjang; Ristic, Arsen D; Straburzynska-Migaj, Ewa; McDonagh, Theresa; Seferovic, Petar; Ruschitzka, Frank.

I: European Journal of Heart Failure, Bind 20, Nr. 11, 2018, s. 1505-1535.

Publikation: Bidrag til tidsskriftReviewfagfællebedømt

Harvard

Crespo-Leiro, MG, Metra, M, Lund, LH, Milicic, D, Costanzo, MR, Filippatos, G, Gustafsson, F, Tsui, S, Barge-Caballero, E, De Jonge, N, Frigerio, M, Hamdan, R, Hasin, T, Hülsmann, M, Nalbantgil, S, Potena, L, Bauersachs, J, Gkouziouta, A, Ruhparwar, A, Ristic, AD, Straburzynska-Migaj, E, McDonagh, T, Seferovic, P & Ruschitzka, F 2018, 'Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology', European Journal of Heart Failure, bind 20, nr. 11, s. 1505-1535. https://doi.org/10.1002/ejhf.1236

APA

Crespo-Leiro, M. G., Metra, M., Lund, L. H., Milicic, D., Costanzo, M. R., Filippatos, G., Gustafsson, F., Tsui, S., Barge-Caballero, E., De Jonge, N., Frigerio, M., Hamdan, R., Hasin, T., Hülsmann, M., Nalbantgil, S., Potena, L., Bauersachs, J., Gkouziouta, A., Ruhparwar, A., ... Ruschitzka, F. (2018). Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 20(11), 1505-1535. https://doi.org/10.1002/ejhf.1236

Vancouver

Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G o.a. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2018;20(11):1505-1535. https://doi.org/10.1002/ejhf.1236

Author

Crespo-Leiro, Maria G ; Metra, Marco ; Lund, Lars H ; Milicic, Davor ; Costanzo, Maria Rosa ; Filippatos, Gerasimos ; Gustafsson, Finn ; Tsui, Steven ; Barge-Caballero, Eduardo ; De Jonge, Nicolaas ; Frigerio, Maria ; Hamdan, Righab ; Hasin, Tal ; Hülsmann, Martin ; Nalbantgil, Sanem ; Potena, Luciano ; Bauersachs, Johann ; Gkouziouta, Aggeliki ; Ruhparwar, Arjang ; Ristic, Arsen D ; Straburzynska-Migaj, Ewa ; McDonagh, Theresa ; Seferovic, Petar ; Ruschitzka, Frank. / Advanced heart failure : a position statement of the Heart Failure Association of the European Society of Cardiology. I: European Journal of Heart Failure. 2018 ; Bind 20, Nr. 11. s. 1505-1535.

Bibtex

@article{7b7c6c9912ad47b7b8e2adedc42e3e94,
title = "Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology",
abstract = "This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 classification of advanced heart failure and describes new diagnostic and treatment options for these patients. Recognizing the patient with advanced heart failure is critical to facilitate timely referral to advanced heart failure centres. Unplanned visits for heart failure decompensation, malignant arrhythmias, co-morbidities, and the 2016 ESC guidelines criteria for the diagnosis of heart failure with preserved ejection fraction are included in this updated definition. Standard treatment is, by definition, insufficient in these patients. Inotropic therapy may be used as a bridge strategy, but it is only a palliative measure when used on its own, because of the lack of outcomes data. Major progress has occurred with short-term mechanical circulatory support devices for immediate management of cardiogenic shock and long-term mechanical circulatory support for either a bridge to transplantation or as destination therapy. Heart transplantation remains the treatment of choice for patients without contraindications. Some patients will not be candidates for advanced heart failure therapies. For these patients, who are often elderly with multiple co-morbidities, management of advanced heart failure to reduce symptoms and improve quality of life should be emphasized. Robust evidence from prospective studies is lacking for most therapies for advanced heart failure. There is an urgent need to develop evidence-based treatment algorithms to prolong life when possible and in accordance with patient preferences, increase life quality, and reduce the burden of hospitalization in this vulnerable patient population.",
keywords = "Cardiology, Diagnostic Techniques, Cardiovascular, Europe, Heart Failure/classification, Heart Transplantation, Heart-Assist Devices, Humans, Societies, Medical",
author = "Crespo-Leiro, {Maria G} and Marco Metra and Lund, {Lars H} and Davor Milicic and Costanzo, {Maria Rosa} and Gerasimos Filippatos and Finn Gustafsson and Steven Tsui and Eduardo Barge-Caballero and {De Jonge}, Nicolaas and Maria Frigerio and Righab Hamdan and Tal Hasin and Martin H{\"u}lsmann and Sanem Nalbantgil and Luciano Potena and Johann Bauersachs and Aggeliki Gkouziouta and Arjang Ruhparwar and Ristic, {Arsen D} and Ewa Straburzynska-Migaj and Theresa McDonagh and Petar Seferovic and Frank Ruschitzka",
note = "{\textcopyright} 2018 The Authors. European Journal of Heart Failure {\textcopyright} 2018 European Society of Cardiology.",
year = "2018",
doi = "10.1002/ejhf.1236",
language = "English",
volume = "20",
pages = "1505--1535",
journal = "European Journal of Heart Failure",
issn = "1567-4215",
publisher = "JohnWiley & Sons Ltd",
number = "11",

}

RIS

TY - JOUR

T1 - Advanced heart failure

T2 - a position statement of the Heart Failure Association of the European Society of Cardiology

AU - Crespo-Leiro, Maria G

AU - Metra, Marco

AU - Lund, Lars H

AU - Milicic, Davor

AU - Costanzo, Maria Rosa

AU - Filippatos, Gerasimos

AU - Gustafsson, Finn

AU - Tsui, Steven

AU - Barge-Caballero, Eduardo

AU - De Jonge, Nicolaas

AU - Frigerio, Maria

AU - Hamdan, Righab

AU - Hasin, Tal

AU - Hülsmann, Martin

AU - Nalbantgil, Sanem

AU - Potena, Luciano

AU - Bauersachs, Johann

AU - Gkouziouta, Aggeliki

AU - Ruhparwar, Arjang

AU - Ristic, Arsen D

AU - Straburzynska-Migaj, Ewa

AU - McDonagh, Theresa

AU - Seferovic, Petar

AU - Ruschitzka, Frank

N1 - © 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.

PY - 2018

Y1 - 2018

N2 - This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 classification of advanced heart failure and describes new diagnostic and treatment options for these patients. Recognizing the patient with advanced heart failure is critical to facilitate timely referral to advanced heart failure centres. Unplanned visits for heart failure decompensation, malignant arrhythmias, co-morbidities, and the 2016 ESC guidelines criteria for the diagnosis of heart failure with preserved ejection fraction are included in this updated definition. Standard treatment is, by definition, insufficient in these patients. Inotropic therapy may be used as a bridge strategy, but it is only a palliative measure when used on its own, because of the lack of outcomes data. Major progress has occurred with short-term mechanical circulatory support devices for immediate management of cardiogenic shock and long-term mechanical circulatory support for either a bridge to transplantation or as destination therapy. Heart transplantation remains the treatment of choice for patients without contraindications. Some patients will not be candidates for advanced heart failure therapies. For these patients, who are often elderly with multiple co-morbidities, management of advanced heart failure to reduce symptoms and improve quality of life should be emphasized. Robust evidence from prospective studies is lacking for most therapies for advanced heart failure. There is an urgent need to develop evidence-based treatment algorithms to prolong life when possible and in accordance with patient preferences, increase life quality, and reduce the burden of hospitalization in this vulnerable patient population.

AB - This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 classification of advanced heart failure and describes new diagnostic and treatment options for these patients. Recognizing the patient with advanced heart failure is critical to facilitate timely referral to advanced heart failure centres. Unplanned visits for heart failure decompensation, malignant arrhythmias, co-morbidities, and the 2016 ESC guidelines criteria for the diagnosis of heart failure with preserved ejection fraction are included in this updated definition. Standard treatment is, by definition, insufficient in these patients. Inotropic therapy may be used as a bridge strategy, but it is only a palliative measure when used on its own, because of the lack of outcomes data. Major progress has occurred with short-term mechanical circulatory support devices for immediate management of cardiogenic shock and long-term mechanical circulatory support for either a bridge to transplantation or as destination therapy. Heart transplantation remains the treatment of choice for patients without contraindications. Some patients will not be candidates for advanced heart failure therapies. For these patients, who are often elderly with multiple co-morbidities, management of advanced heart failure to reduce symptoms and improve quality of life should be emphasized. Robust evidence from prospective studies is lacking for most therapies for advanced heart failure. There is an urgent need to develop evidence-based treatment algorithms to prolong life when possible and in accordance with patient preferences, increase life quality, and reduce the burden of hospitalization in this vulnerable patient population.

KW - Cardiology

KW - Diagnostic Techniques, Cardiovascular

KW - Europe

KW - Heart Failure/classification

KW - Heart Transplantation

KW - Heart-Assist Devices

KW - Humans

KW - Societies, Medical

U2 - 10.1002/ejhf.1236

DO - 10.1002/ejhf.1236

M3 - Review

C2 - 29806100

VL - 20

SP - 1505

EP - 1535

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1567-4215

IS - 11

ER -

ID: 218469158